ResearcherUniversity College LondonActive in the last 2 years
Darragh Patrick O'Brien
Matched on ORCID iD 0000-0003-4924-7795; OpenAlex author ID A5015209073. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Multi-protein panel in pancreatic cyst fluid for improved risk stratification for pancreatic cancer First author DOI 10.1101/2025.09.17.25335852↗
- Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus. Co-author DOI 10.1158/1078-0432.ccr-15-0879↗
- Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Co-author DOI 10.1158/1078-0432.ccr-14-0365↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dimitrios Manolis · 1 shared paper, 2025 · strength 0.22
- Leonid L. Nikitenko · 1 shared paper, 2025 · strength 0.22
- Anthony Maraveyas · 1 shared paper, 2025 · strength 0.22
- David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.22
- Hemant Mahendrakumar Kocher · 1 shared paper, 2025 · strength 0.22
- Claire Jenkinson · 2 shared papers, 2015–2016 · strength 0.08
- Paper Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Asso… DOI 10.1158/1078-0432.ccr-15-0879↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- Stephen P. Pereira · 2 shared papers, 2015–2016 · strength 0.08
- Paper Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Asso… DOI 10.1158/1078-0432.ccr-15-0879↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- John F. Timms · 2 shared papers, 2015–2016 · strength 0.08
- Paper Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Asso… DOI 10.1158/1078-0432.ccr-15-0879↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- Eithne Costello · 2 shared papers, 2015–2016 · strength 0.08
- Paper Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Asso… DOI 10.1158/1078-0432.ccr-15-0879↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- Lucy S. Oldfield · 1 shared paper, 2016 · strength 0.04
- John P. Neoptolemos · 1 shared paper, 2016 · strength 0.04
- William Greenhalf · 1 shared paper, 2016 · strength 0.04
- David Arthur Tuveson · 1 shared paper, 2016 · strength 0.04
- Alexey A. Zaikin · 1 shared paper, 2015 · strength 0.04
- Ross C. Smith · 1 shared paper, 2015 · strength 0.04
- Oleg B. Blyuss · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.